BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Compression Therapy Market is Anticipated to Reach a Market Value of US$ 4.59 Billion By 2030 - Comprehensive Research Report By FMI

  DUBAI, United Arab Emirates, The USD 4.59 billion compression therapy market is likely to grow witness 5.4% CAGR through 2030, despite the COVID-19 blip, according to market research firm Future Market Insights.

  April 26, 2022

   · 

  5 min read
• Manual Resuscitator Market Is Set to Experience a Significant Growth Of 5.7% CAGR From 2022 To 2030 - Comprehensive Research Report By FMI

  DUBAI, United Arab Emirates, The global manual resuscitator market is set to surpass a valuation of USD 845.3 million by 2030, according to a research by ESOMAR-certified firm Future Market Insights.

  April 26, 2022

   · 

  6 min read
• Stomach Cancer Drugs Market: Rising Number of Cases of Chronic Atrophic Gastritis to Drive the Market

  Albany NY, United States: Stomach cancer is one of the prevailing diseases among various types of cancers that are on the rise.

  April 26, 2022

   · 

  5 min read
• Orthotic Devices, Casts, and Splints Market is Anticipated to Reach a Market Value of US$ 3.32 Billion By 2024 - Comprehensive Research Report By FMI

  DUBAI, United Arab Emirates, The orthotic devices, casts and splints market will witness a CAGR of 6.2% between 2022 and 2024, according to a latest report by ESOMAR-certified market research firm Future Market Insights.

  April 26, 2022

   · 

  5 min read
• Pharmaceutical Intermediates Market to cross US$ 53.4 Bn by 2031, rise in healthcare expenditure and focus on research & development to drive the market

  Rise in healthcare expenditure and focus on research & development are anticipated to drive the global pharmaceutical intermediates market from 2021 to 2031.

  April 26, 2022

   · 

  5 min read
• Active Biotech strengthens the patent protection for laquinimod in eye disorders

  Active Biotech announced that the European Patent Office has issued a decision to grant Active Biotech’s patent related to use of laquinimod as treatment of eye diseases associated with excessive vascularization.

  April 26, 2022

   · 

  3 min read
• Business

  Mainz Biomed Appoints Darin Leigh as Chief Commercial Officer

  Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced the appointment of Darin Leigh as Chief Commercial Officer.

  April 26, 2022

   · 

  7 min read
• AI Medical Service Inc. Announces 8 Billion JPY (US$70 M) Series C Financing Led by SoftBank Vision Fund 2 (SVF2)

  AI Medical Service Inc. has announced 8 billion JPY ( US$70 million ) of financing led by SoftBank Vision Fund 2 (SVF2),

  April 26, 2022

   · 

  3 min read
• Octapharma to address unmet needs in von Willebrand disease as a proud sponsor of WFH 2022 World Congress

  As part of its ongoing commitment to the global bleeding disorders community, Octapharma is pleased to be a Gold Sponsor of the upcoming World Federation of Haemophilia 2022 World Congress, taking place from May 8 to 11, 2022.

  April 26, 2022

   · 

  3 min read
• Business

  Calyxt Announces Strategic Hires in Business Development and Manufacturing

  Calyxt, Inc., a plant-based synthetic biotechnology company, yesterday welcomed the second of two director-level hires in areas critical to the continued advancement of the Company’s key technology and business development goals.

  April 26, 2022

   · 

  7 min read